<DOC>
	<DOCNO>NCT02719145</DOCNO>
	<brief_summary>This cross sectional study carry 30 subject recruit outpatient clinic Chest Department , Tanta University Hospital . They classify 3 group : Group I : It include 10 healthy volunteer subject . Group II : It include 10 asthmatic patient . Group III : It include 10 COPD patient . miR-7 , miR-20a , miR-21 , miR-22 , miR-145 miR-155 measure serum sample subject</brief_summary>
	<brief_title>Circulating Micro RNAs Expression Egyptian Bronchial Asthma COPD Patients</brief_title>
	<detailed_description>The follow do subject : 1 . Thorough history take stress age , age onset , duration disease , smoke history , therapeutic history stress drug , course disease , history previous attack acute severe asthma exacerbation COPD . 2 . Complete physical examination . 3 . Chest x-ray P.A view . 4 . Complete blood picture . 5 . Ventilatory function test include FVC , FEVI FEVI/FVC , PEFR FEF25-75 % use computerized spirometry apparatus . Quantitative assessment miRNA level : use assay miR-7 , miR-20a , miR-21 , miR-22 , miR-145 miR-155 serum sample subject . These miRNAs select base prediction algorithm suggest miRNAs involve regulation cytokine .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Group 1 : healthy volunteer history chest trouble . Group 2 : 10 asthmatic patient history paroxysmal wheezing , dyspnea , chest distress , and/or coughing ; Reversible airflow limitation measure increase force expiratory volume one second ( FEV1 ) least 12 % 200 ml inhalation 200 μg salbutamol . Group 3 : 10 COPD patient chronic airﬂow limitation spirometry ( FEV1/FVC less 0.7 ) , patient irreversible airflow limitation measure increase ( FEV1 ) less than12 % le 200 ml inhalation 200 μg salbutamol . Upper low respiratory tract infection month precede study . Other chronic respiratory systemic illness . Usage systemic steroid within 2 month prior study . Inability provide inform consent refuse draw blood .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>micro RNA</keyword>
	<keyword>asthma</keyword>
	<keyword>COPD</keyword>
</DOC>